If you need any specific information about Technical Data Sheet product, please do not hesitate to contact us at: info@kernpharma.com.
Product List CTD – Medicinal Product Auditable & Routine
Therapeutical area | Product | Dose | Pharmaceutical form | Date of dossier development | Editar producto |
---|---|---|---|---|---|
Analgesics
|
Paracetamol | 500 mg 650 mg 1 g |
Oral solution (Stick Pack) | 2014 | |
Analgesics
|
Paracetamol | 500 mg 650 mg 1 g |
Oral solution (Stick Pack) | 2014 | |
Analgesics
|
Paracetamol | 500 mg 650 mg 1 g |
Tablets | 2005 | |
Analgesics
|
Paracetamol | 500 mg 650 mg 1 g |
Tablets | 2005 | |
Analgesics
|
Fentanyl | 100 mcg 200 mcg 300 mcg 400 mcg 600 mcg 800 mcg |
Sublingual tablets | 2017 | |
Analgesics
|
Fentanyl | 100 mcg 200 mcg 300 mcg 400 mcg 600 mcg 800 mcg |
Sublingual tablets | 2017 | |
Antifungals
|
Ketoconazole | 20 mg/g | Cream | 2017 | |
Antifungals
|
Ketoconazole | 20 mg/g | Cream | 2017 | |
Antiinfectives
|
Clarithromycin | 250 mg 500 mg |
Film-coated tablets | 2001 | |
Antiinfectives
|
Clarithromycin | 250 mg 500 mg |
Film-coated tablets | 2001 | |
Antiinfectives
|
Azithromycin | 500 mg | Film-coated tablets | 2000 | |
Antiinfectives
|
Azithromycin | 500 mg | Film-coated tablets | 2000 | |
Antiinflamatories
|
Ibuprofen | 400 mg 600 mg |
Film-coated tablets | 2001 | |
Antiinflamatories
|
Ibuprofen | 400 mg 600 mg |
Film-coated tablets | 2001 | |
Antiinflamatories
|
Diclofenac | 11.6 mg/g | Gel | 2008 | |
Antiinflamatories
|
Diclofenac | 11.6 mg/g | Gel | 2008 | |
Antiinflamatories
|
Dexamethasone (with preservatives) |
4 mg/ml | Solution for injection | 2019 | |
Antiinflamatories
|
Dexamethasone (with preservatives) |
4 mg/ml | Solution for injection | 2019 | |
Antiinflamatories
|
Diclofenac | 23.2 mg/g | Gel | 2019 | |
Antiinflamatories
|
Diclofenac | 23.2 mg/g | Gel | 2019 | |
Antiinflamatories
|
Prednisone | 5 mg 10 mg 30 mg |
Tablets | 2004 | |
Antiinflamatories
|
Prednisone | 5 mg 10 mg 30 mg |
Tablets | 2004 | |
Antiinflamatories
|
Ibuprofen | 200 mg 400 mg 600 mg |
Oral suspension (Stick Pack) | 2014 | |
Antiinflamatories
|
Ibuprofen | 200 mg 400 mg 600 mg |
Oral suspension (Stick Pack) | 2014 | |
C.N.S.
|
Memantine | 10 mg 20 mg |
Tablets | 2010 | |
C.N.S.
|
Sulpiride | 50 mg | Capsules | 2005 | |
C.N.S.
|
Memantine | 10 mg 20 mg |
Tablets | 2010 | |
C.N.S.
|
Sulpiride | 50 mg | Capsules | 2005 | |
C.N.S.
|
Memantine | 10 mg/ml | Oral solution | 2010 | |
C.N.S.
|
Diazepam | 2.5 mg 5 mg 10 mg 25 mg |
Tablets | 2010 | |
C.N.S.
|
Memantine | 10 mg/ml | Oral solution | 2010 | |
C.N.S.
|
Diazepam | 2.5 mg 5 mg 10 mg 25 mg |
Tablets | 2010 | |
C.N.S.
|
Naloxone | 0.4 mg/ml | Solution for injection | 2010 | |
C.N.S.
|
Naloxone | 0.4 mg/ml | Solution for injection | 2010 | |
C.N.S.
|
Betahistine | 24 mg 8 mg 16 mg |
Tablets | 2019 | |
C.N.S.
|
Betahistine | 24 mg 8 mg 16 mg |
Tablets | 2019 | |
C.N.S.
|
Aripiprazole | 5 mg 10 mg 15 mg 30 mg |
Tablets | 2014 | |
C.N.S.
|
Aripiprazole | 5 mg 10 mg 15 mg 30 mg |
Tablets | 2014 | |
C.N.S.
|
Aripiprazole | 1 mg/ml | Oral solution | 2014 | |
C.N.S.
|
Aripiprazole | 1 mg/ml | Oral solution | 2014 | |
C.N.S.
|
Lorazepam | 1 mg 2.5 mg 5 mg |
Tablets | 2014 | |
C.N.S.
|
Pregabalin | 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 300 mg |
Capsules | 2011 | |
C.N.S.
|
Lorazepam | 1 mg 2.5 mg 5 mg |
Tablets | 2014 | |
C.N.S.
|
Pregabalin | 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 300 mg |
Capsules | 2011 | |
C.N.S.
|
Lormetazepam | 0.5 mg 1 mg 2 mg |
Tablets | 2008 | |
C.N.S.
|
Bromazepam | 1.5 mg 3 mg |
Capsules | 2008 | |
C.N.S.
|
Lormetazepam | 0.5 mg 1 mg 2 mg |
Tablets | 2008 | |
C.N.S.
|
Bromazepam | 1.5 mg 3 mg |
Capsules | 2008 | |
Cardiovascular
|
Propranolol | 10 mg 40 mg |
Tablets | 2017 | |
Cardiovascular
|
Propranolol | 10 mg 40 mg |
Tablets | 2017 | |
Cardiovascular
|
Irbesartan | 75 mg 150 mg 300 mg |
Film-coated tablets | 2008 | |
Cardiovascular
|
Irbesartan | 75 mg 150 mg 300 mg |
Film-coated tablets | 2008 | |
Cardiovascular
|
Digoxin | 0.25 mg/ml (2ml) | Solution for injection | 2010 | |
Cardiovascular
|
Irbesartan/HCTZ | 150/12.5 mg 300/12.5 mg 300/25 mg |
Film-coated tablets | 2009 | |
Cardiovascular
|
Irbesartan/HCTZ | 150/12.5 mg 300/12.5 mg 300/25 mg |
Film-coated tablets | 2009 | |
Cardiovascular
|
Digoxin | 0.25 mg/ml (2ml) | Solution for injection | 2010 | |
Cardiovascular
|
Labetalol | 5 mg/ml | Solution for injection | 2010 | |
Cardiovascular
|
Ambrisentan | 5 mg 10 mg |
Tablets | 2018 | |
Cardiovascular
|
Digoxin | 0.25 mg | Tablets | 2010 | |
Cardiovascular
|
Labetalol | 5 mg/ml | Solution for injection | 2010 | |
Cardiovascular
|
Ambrisentan | 5 mg 10 mg |
Tablets | 2018 | |
Cardiovascular
|
Digoxin | 0.25 mg | Tablets | 2010 | |
Cardiovascular
|
Furosemida | 40 mg | Tablets | 2004 | |
Cardiovascular
|
Furosemida | 40 mg | Tablets | 2004 | |
Cardiovascular
|
Rosuvastatin | 5 mg 10 mg 20 mg 40 mg |
Film-coated tablets | 2014 | |
Cardiovascular
|
Rosuvastatin | 5 mg 10 mg 20 mg 40 mg |
Film-coated tablets | 2014 | |
Contraceptives
|
Etonogestrel Ethinylestradiol | 0.120 mg 0.015 mg (per 24 hours) |
Vaginal delivery system | 2017 | |
Contraceptives
|
Etonogestrel Ethinylestradiol | 0.120 mg 0.015 mg (per 24 hours) |
Vaginal delivery system | 2017 | |
Musculoskeletal
|
Chondroitin sulfate | 400 mg | Capsules | 2014 | |
Musculoskeletal
|
Vitamin D3 | 2,000 IU/ml | Oral solution | 2019 | |
Musculoskeletal
|
Chondroitin sulfate | 400 mg | Capsules | 2014 | |
Musculoskeletal
|
Vitamin D3 | 2,000 IU/ml | Oral solution | 2019 | |
Musculoskeletal
|
Vitamin D3 | 25,000 IU/ml | Oral solution | 2019 | |
Musculoskeletal
|
Vitamin D3 | 25,000 IU/ml | Oral solution | 2019 | |
Oncology
|
Imatinib | 100 mg 400 mg |
Film-coated tablets | 2014 | |
Oncology
|
Imatinib | 100 mg 400 mg |
Film-coated tablets | 2014 | |
Oncology
|
Letrozole | 2.5 mg | Tablets | 2007 | |
Oncology
|
Letrozole | 2.5 mg | Tablets | 2007 | |
Oral Antidiabetics
|
Vildagliptin | 50 mg | Tablets | 2016 | |
Oral Antidiabetics
|
Vildagliptin | 50 mg | Tablets | 2016 | |
Oral Antidiabetics
|
Vildagliptin/Metformin | 50/850 mg 50/1000 mg |
Film-coated tablets | 2019 | |
Oral Antidiabetics
|
Vildagliptin/Metformin | 50/850 mg 50/1000 mg |
Film-coated tablets | 2019 | |
Oral Antidiabetics
|
Sitagliptin/Metformin | 50/850 mg 50/1000 mg |
Film-coated tablets | 2019 | |
Oral Antidiabetics
|
Sitagliptin/Metformin | 50/850 mg 50/1000 mg |
Film-coated tablets | 2019 | |
Respiratory System
|
Cold relief capsules Parecetamol Chlorphenamine Dextromethorphan Pseudoephedrine |
500 mg 2 mg 15 mg 30 mg |
Capsules | 2019 | |
Respiratory System
|
Cold relief capsules Parecetamol Chlorphenamine Dextromethorphan Pseudoephedrine |
500 mg 2 mg 15 mg 30 mg |
Capsules | 2019 | |
Urology
|
Solifenacin | 5 mg 10 mg |
Film-coated tablets | 2017 | |
Urology
|
Tadalifo | 5 mg 10 mg 20 mg |
Film-coated tablets | 2017 | |
Urology
|
Solifenacin | 5 mg 10 mg |
Film-coated tablets | 2017 | |
Urology
|
Tadalifo | 5 mg 10 mg 20 mg |
Film-coated tablets | 2017 | |
Venous System
|
Diosmin/Hesperidin (FFP) | 450/50 mg | Tablets | 2017 | |
Venous System
|
Diosmin/Hesperidin | 450/50 mg | Tablets | 2008 | |
Venous System
|
Diosmin/Hesperidin (FFP) | 450/50 mg | Tablets | 2017 | |
Venous System
|
Diosmin/Hesperidin | 450/50 mg | Tablets | 2008 | |
Venous System
|
Diosmin/Hesperidin (FFP) | 900/100 mg | Tablets | 2019 | |
Venous System
|
Diosmin/Hesperidin (FFP) | 900/100 mg | Tablets | 2019 |
List CTD Drug Product Under Development
Therapeutical area | Product | Dose | Pharmaceutical form | Date of dossier development | Editar producto |
---|---|---|---|---|---|
Gastrointestinal
|
Metoclopramide | 1mg/ml | Oral solution (Flask) | Q3 2020 | |
Gastrointestinal
|
Metoclopramide | 1mg/ml | Oral solution (Flask) | Q3 2020 | |
Musculoskeletal
|
Naproxen sodium | 550 mg | Film-coated tablets | Q1 2020 | |
Musculoskeletal
|
Naproxen sodium | 550 mg | Film-coated tablets | Q1 2020 | |
Musculoskeletal
|
Vitamin D3 | 20.000 IU |
Soft capsules | Q2 2020 | |
Musculoskeletal
|
Vitamin D3 | 20.000 IU |
Soft capsules | Q2 2020 | |
Oral Antidiabetics
|
Sitagliptin | 25 mg 50 mg 100 mg |
Film-coated tablets | Q3 2020 | |
Oral Antidiabetics
|
Sitagliptin | 25 mg 50 mg 100 mg |
Film-coated tablets | Q3 2020 | |
Respiratory System
|
Hedera Helix Syrup | 35mg/5ml | Oral solution (Stick pack & Flask) | Q4 2020 | |
Respiratory System
|
Hedera Helix Syrup | 35mg/5ml | Oral solution (Stick pack & Flask) | Q4 2020 | |
Venous System
|
Rivaroxaban | 10 mg 15 mg 20 mg |
Film-coated tablets | Q1 2022 | |
Venous System
|
Rivaroxaban | 10 mg 15 mg 20 mg |
Film-coated tablets | Q1 2022 |